- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.02. | CHULARAT HOSPITAL PCL: Management Discussion and Analysis Yearly Ending 31 Dec 2023 (Revised) | 1 | Stock Exchange of Thailand | ||
| 15.11.23 | CHULARAT HOSPITAL PCL: Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023 | 1 | Stock Exchange of Thailand |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 60,61 | +14,40 % | Procept GAAP EPS of -$0.51, revenue of $44.5M | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 21,430 | -13,06 % | Mobile-health Retreats on Opening New Pharmacy | ||
| ATRICURE | 24,810 | +2,78 % | AtriCure Q1 2024 Earnings Preview | ||
| GENEDX | 20,880 | +21,89 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| PROGYNY | 32,270 | +0,62 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| ADAPTHEALTH | 10,060 | +2,13 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| RXSIGHT | 56,73 | +8,93 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CVRX | 10,120 | -34,71 % | Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN. | WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86.
TG... ► Artikel lesen | |
| MIMEDX | 7,300 | +18,70 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| AGILON HEALTH | 4,955 | -9,83 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,000 | -2,17 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| AGILITI | 10,105 | -0,44 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
| NANO-X IMAGING | 9,150 | +2,12 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| DOCGO | 3,390 | +0,30 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
| CASTLE BIOSCIENCES | 22,060 | +4,55 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen |
CHULARAT HOSPITAL PCL gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
